RA Kyle

1.3k citations
17 papers · 826 · h-index 12

Impact in

  • Hematology top 2%
    • Multiple Myeloma Research and Treatments
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Multiple Myeloma Research and Treatments 12
    • Cancer Treatment and Pharmacology 3
    • Peptidase Inhibition and Analysis 2
    • Chemokine receptors and signaling 1

RA Kyle

14 papers receiving 809 citations

Peers

RA Kyle
Comparison fields: 5 of 61
  • Hematology 540
  • Genetics 163
  • Oncology 297
  • Nephrology 73
  • Molecular Biology 542
Replace Lian X. Tang with:
Lian X. Tang United Kingdom
Cindy Varga United States
Eurydiki Michalis Greece
Sosana Delimpasi Greece
Alfonso García de Coca Spain
Josefina Galende Spain
Zdeněk Adam Czechia
Salvatore Palmieri Italy
Paola Masolini Italy
Miguel‐Teodoro Hernández Spain
RA Kyle relative to Lian X. Tang United Kingdom Lian X. Tang's profile →
Citations per field
00.5×1.6×
Lian X. Tang · 1×
Citations per year

Countries citing papers authored by RA Kyle

Since Specialization
Citations

This map shows the geographic impact of RA Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Kyle more than expected).

Fields of papers citing papers by RA Kyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RA Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Kyle. The network helps show where RA Kyle may publish in the future.

Co-authors

The 25 scholars most cited alongside RA Kyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with RA Kyle Line = papers co-authored together RA Kyle links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 1993241
2 1986164
3 1988142
4 199449
5 199448
6 200747
7 201338
8 199830
9
High-dose therapy in multiple myeloma and primary amyloidosis: an overview.
199917
10
Clinical aspects of multiple myeloma and related disorders including amyloidosis.
199916
11 199015
12 199513
13 19794
14 20091
15 19851
16 20090
17 20210

About RA Kyle

RA Kyle is a scholar working on Hematology, Oncology, Molecular Biology, Nephrology and Genetics, having authored 17 papers that have together received 826 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cancer Treatment and Pharmacology (3 papers), Parathyroid Disorders and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Chemokine receptors and signaling (1 paper) and Neuroscience of respiration and sleep (1 paper). The work is most often cited by research in Hematology (540 citations), Genetics (163 citations), Oncology (297 citations), Nephrology (73 citations) and Molecular Biology (542 citations). RA Kyle has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include PR Greipp, W. Michael O’Fallon, JA Katzmann, JA Lust, TE Witzig, Angela Dispenzieri, A. Jamil Tajik, MQ Lacy, Patricia A. Pellikka and Karen Modesto. Their work appears in journals such as Blood, JAMA, Blood Reviews, Bone Marrow Transplantation and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact